Expert: Humanized monoclonal antibody that binds complement C5, preventing cleavage to C5a and C5b and inhibiting terminal complement-mediated hemolysis and inflammation.

Everyday: Blocks a protein in the immune system that mistakenly attacks the body's own red blood cells.

Targets: ["C5"]

Zilucoplan, a macrocyclic peptide C5 complement inhibitor for generalized myasthenia gravis. Self-administered daily subcutaneous injection; smaller molecule than monoclonal antibodies allows convenient home dosing.